[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650941":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":30,"responsibleParty":47,"collaborators":19,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":19,"eligibilityCriteria":54,"healthyVolunteers":51,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":19,"overallStatus":66,"whyStopped":19,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Phase I Feasibility Cohort: Remote IC Process for Non-Therapeutic Studies","EXPERIMENTAL","All participants will be provided with an abbreviated informed consent form describing this study and providing sufficient information for patients to make an informed decision regarding participation.",[13],"Other: CoCo Chatbot",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"CoCo Chatbot","A patient-facing chatbot designed to obtain informed consent",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Funda Meric-Bernstam, MD","UT MD Anderson","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","(713) 794-1226","fmeric@mdanderson.org",[31],{"facility":23,"status":19,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Houston","Texas","77030","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-95.36327,29.76328,{"lat":41,"lon":40},[44,46],{"name":22,"role":27,"phone":45,"phoneExt":19,"email":29},"713-794-1226",{"name":22,"role":24,"phone":19,"phoneExt":19,"email":19},{"type":48,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100650941","chatbot-implementation-in-the-clinical-informed-consent-process-100650941",false,"NCT07756515","Chatbot Implementation In The Clinical Informed Consent Process","Inclusion Criteria:\n\n* Ability to understand and willingness to provide informed consent.\n* Age ≥18 years.\n* Patients whose preferred language is English.\n* Patients who are being considered for enrollment in selected clinical research studies.\n\nPhase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study.\n\nExclusion Criteria:\n\nN\u002FA","ALL","18 Years",{"count":58,"type":59},100,"ESTIMATED","INTERVENTIONAL",[62],"NA","The purpose of this study is to determine the feasibility of implementing the chatbot \"CoCo\" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.",[65],"Informed Consent","NOT_YET_RECRUITING","2026-08-07",{"date":69,"type":70},"2026-08-10","ACTUAL",{"date":72,"type":59},"2027-01-01",{"date":74,"type":59},"2031-12-17",{"name":5,"class":6},1]